Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|January 13, 2005
Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFREdwin Bremer, Douwe F Samplonius, Linda van Genne, et al.
ACS Chemical Biology|February 6, 2024
Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming ProteinJana Volarić, Nieck J van der Heide, Natalie L Mutter, et al.
Immunology Letters|April 26, 2011
Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signalingEdwin Bremer, Wayel H Abdulahad, Marco de Bruyn, et al.
Oncoimmunology|July 3, 2015
CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancerMarco de Bruyn, Valerie R Wiersma, Maartje C A Wouters, et al.
Cancer Letters|August 31, 2021
Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesiclesEmily M Ploeg, Xiurong Ke, Isabel Britsch, et al.
Cancer Research|April 19, 2005
Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7Edwin Bremer, Douwe F Samplonius, Matthias Peipp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Cell surface delivery of TRAIL strongly augments the tumoricidal activity of T cellsMarco de Bruyn, Yunwei Wei, Valerie R Wiersma, et al.
Cancer Research|January 18, 2008
Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonistsEdwin Bremer, Bram ten Cate, Douwe F Samplonius, et al.
Plos One|June 7, 2013
Galectin-9 activates and expands human T-helper 1 cellsMarloes J M Gooden, Valerie R Wiersma, Douwe F Samplonius, et al.
Mabs|March 12, 2015
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicityValerie R Wiersma, Marco de Bruyn, Ce Shi, et al.
Pageof 3